Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bellerophon Ther Com (BLPH)

Bellerophon Ther Com (BLPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,186
  • Shares Outstanding, K 9,498
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,270 K
  • 60-Month Beta -0.78
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 37.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.68
  • Number of Estimates 2
  • High Estimate -0.65
  • Low Estimate -0.70
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +24.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.85 +9.45%
on 06/11/20
13.93 -6.89%
on 06/16/20
+0.15 (+1.17%)
since 06/10/20
3-Month
10.80 +20.09%
on 04/13/20
21.28 -39.05%
on 05/12/20
+1.55 (+13.57%)
since 04/09/20
52-Week
3.19 +307.11%
on 03/19/20
26.00 -50.12%
on 03/20/20
+3.50 (+36.92%)
since 07/10/19

Most Recent Stories

More News
Bellerophon Therapeutics Added to Russell 3000(R) and Microcap(R) Indexes

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases, today announced that the company...

BLPH : 12.97 (-0.38%)
Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) ("Bellerophon" or the "Company") today announced the closing of its previously announced public offering and concurrent registered direct offering (the "Offerings")...

BLPH : 12.97 (-0.38%)
Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct Offering

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) ("Bellerophon" or the "Company") today announced the pricing of offerings for an aggregate of 3,076,923 shares of its common stock at a public offering price...

BLPH : 12.97 (-0.38%)
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) ("Bellerophon" or the "Company") today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering....

BLPH : 12.97 (-0.38%)
Company News for May 12, 2020

Companies In The News Are:

BLPH : 12.97 (-0.38%)
MYOK : 92.86 (-0.29%)
APOP : 3.13 (-2.19%)
AMRX : 4.65 (+6.65%)
Bellerophon Therapeutics: 1Q Earnings Snapshot

WARREN, N.J. (AP) _ Bellerophon Therapeutics Inc. (BLPH) on Monday reported a loss of $5 million in its first quarter.

BLPH : 12.97 (-0.38%)
Bellerophon Provides Clinical Program Update and Reports First Quarter 2020 Financial Results

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), ("Bellerophon" or the "Company") a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases,...

BLPH : 12.97 (-0.38%)
Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse(R) Inhaled Nitric Oxide Therapy to Treat COVID-19

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases,...

BLPH : 12.97 (-0.38%)
Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that Fabian Tenenbaum, Chief Executive...

BLPH : 12.97 (-0.38%)
Bellerophon Therapeutics Submits Investigational New Drug Application to Study INOpulse(R) Inhaled Nitric Oxide Therapy for the Treatment of COVID-19

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced the submission of an Investigational...

BLPH : 12.97 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BLPH with:

Business Summary

Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company's product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton,...

See More

Key Turning Points

2nd Resistance Point 13.43
1st Resistance Point 13.20
Last Price 12.97
1st Support Level 12.80
2nd Support Level 12.63

See More

52-Week High 26.00
Fibonacci 61.8% 17.29
Fibonacci 50% 14.59
Last Price 12.97
Fibonacci 38.2% 11.90
52-Week Low 3.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar